I have not heard anybody discuss how the individual patient would compare to the ITT population of the wonder drug's P3 where it established 80% OS.
This goes to 2 issues, one is tags "real world" odds of being positive. Another is that negatives might well have some related condition that is affecting survival.
I kind of suspect though that entire point of this has nothing to do with the answer, but that fact that one has to keep digging past the surface. Both in Clarks's puzzle and real world biotech results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.